山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (9): 24-30.doi: 10.6040/j.issn.1671-7554.0.2022.0822
阮祥燕,程姣姣,杜娟,谷牧青
RUAN Xiangyan, CHENG Jiaojiao, DU Juan, GU Muqing
摘要： 卵巢组织冻存移植技术是近年来新兴的生育力保护技术,不仅可保护患者生育力,还可以保护卵巢内分泌功能。无需卵巢刺激,不延迟后续抗癌治疗,一次可冻存成千上万个卵泡,移植后可实现自然妊娠,是青春期女童和无法延迟抗癌治疗年轻女性的唯一生育力保护方法。2019年美国生殖医学学会声称卵巢组织冻存移植技术不再是试验性技术。
中图分类号:
| [1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30. [2] Rebar RW, Keator CS. Expanding our knowledge of premature ovarian insufficiency[J]. Fertil Steril, 2021,115(2): 328-329. [3] Dolmans MM, Falcone T, Patrizio P. Importance of patient selection to analyze in vitro fertilization outcome with transplanted cryopreserved ovarian tissue[J]. Fertil Steril, 2020,114(2): 279-280. [4] Ruan X. Chinese society of gynecological endocrinology affiliated to the international society of gynecological endocrinology guideline for ovarian tissue cryopreservation and transplantation[J]. Gynecol Endocrinol, 2018, 34(12): 1005-1010. [5] 国际妇科内分泌学会中国妇科内分泌学分会及共识专家. 卵巢组织冻存与移植中国专家共识[J]. 中国临床医生杂志, 2018, 46(4): 496-500. [6] Dolmans MM, Donnez J, Cacciottola L. Fertility Preservation: The challenge of freezing and transplanting ovarian tissue[J]. Trends Mol Med, 2021, 27(8): 777-791. [7] Polyzos NP, Ayoubi JM, Pirtea P. General infertility workup in times of high assisted reproductive technology efficacy[J]. Fertil Steril, 2022, 118(1): 8-18. [8] Anderson RA, Cameron D, Clatot F, et al. Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review[J]. Hum Reprod Update, 2022, 28(3): 417-434. [9] Liebenthron J, Reinsberg J, van der Ven K, et al. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation[J]. Hum Reprod, 2019, 34(12): 2513-2522. [10] Prescott J, Farland LV, Tobias DK, et al. A prospective cohort study of endometriosis and subsequent risk of infertility[J]. Hum Reprod, 2016, 31(7): 1475-1482. [11] Latif S, Saridogan E, Yasmin E. Fertility preservation for women with ovarian endometriosis: it is time to adopt it as routine practice: FOR: Fertility preservation is an integral component of the management of women with ovarian endometriosis: FOR: Fertility preservation is an integral component of the management of women with ovarian endometriosis[J]. BJOG, 2022. doi: 10.1111/1471-0528.17168. [12] Hirsch M, Becker C, Davies M. Fertility preservation for women with ovarian endometriosis: it is time to adopt this as routine practice[J]. BJOG, 2022. doi: 10.1111/1471-0528.17166. [13] Szymanska KJ, Tan X, Oktay K. Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging[J]. Mol Hum Reprod, 2020, 26(8): 553-566. [14] Ruan X, Cheng J, Du J, et al. Analysis of fertility preservation by ovarian tissue cryopreservation in pediatric children in China[ J]. Front Endocrinol(Lausanne), 2022, 13: 930786. doi: 10.3389/fendo.2022.930786. [15] Santaballa A,Márquez-Vega C, Rodríguez-Lescureá, et al. Multidisciplinary consensus on the criteria for fertility preservation in cancer patients[J]. Clin Transl Oncol, 2022, 24(2): 227-243. [16] Corkum KS, Laronda MM, Rowell EE. A review of reported surgical techniques in fertility preservation for prepubertal and adolescent females facing a fertility threatening diagnosis or treatment[J]. Am J Surg, 2017, 214(4): 695-700. [17] Takae S, Furuta S, Iwahataa H, et al. Cryopreservation of paediatric ovarian tissue with an updated version of the Edinburgh criteria for appropriate patient selection[J]. Reprod Biomed Online, 2022, 44(4): 667-676. [18] Isachenko E, Isachenko V, Nawroth F, et al. Effect of long-term exposure at suprazero temperatures on activity and viability of human ovarian cortex[J]. Fertil Steril, 2009, 91(4 suppl): 1556-1559. [19] Beckmann MW, Lotz L, Toth B, et al. Concept paper on the technique of cryopreservation, removal and transplantation of ovarian tissue for fertility preservation[J]. Geburtshilfe Frauenheilkd, 2019, 79(1): 53-62. [20] Liebenthron J, Montag M, Reinsberg J, et al. Overnight ovarian tissue transportation for centralized cryobanking: a feasible option[J]. Reprod Biomed Online, 2019, 38(5): 740-749. [21] von Wolff M, Andersen CY, Woodruff TK, et al. Ferti PROTEKT, oncofertility consortium and the Danish fertility-preservation networks- what can we learn from their experiences?[J]. Clin Med Insights Reprod Health, 2019, 13: 1179558119845865. doi:10.1177/1179558119845865. [22] Liebenthron J, Montag M. Cryopreservation and thawing of human ovarian cortex tissue slices[J]. Methods Mol Biol, 2021, 2180: 485-499. [23] Khattak H, Malhas R, Craciunas L, et al. Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis[J]. Hum Reprod Update, 2022, 28(3): 400-416. [24] Hossay C, Donnez J, Dolmans MM. Whole ovary cryopreservation and transplantation: a systematic review of challenges and research developments in animal experiments and humans[J]. J Clin Med, 2020, 9(10): 3196. [25] Practice Committee of American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion[J]. Fertil Steril, 2014, 101(5): 1237-1243. [26] Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue[J]. Lancet, 2004, 364(9443): 1405-1410. [27] Stern CJ, Gook D, Hale LG, et al. First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy[J]. Hum Reprod, 2013, 28(11): 2996-2999. [28] Dolmans MM, von Wolff M, Poirot C, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers[J]. Fertil Steril, 2021, 115(5): 1102-1115. [29] ESHRE Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, et al. ESHRE guideline: female fertility preservation[J]. Hum Reprod Open, 2020, 2020(4): hoaa052. doi: 10.1093/hropen/hoaa052. [30] Roness H, Meirow D. FERTILITY PRESERVATION: Follicle reserve loss in ovarian tissue transplantation[J]. Reproduction, 2019, 158(5): F35-F44. [31] Cacciottola L, Nguyen TYT, Chiti MC, et al. Long-term advantages of ovarian reserve maintenance and follicle development using adipose tissue-derived stem cells in ovarian tissue transplantation[J]. J Clin Med, 2020, 9(9): E2980. doi: 10.3390/jcm9092980. [32] Manavella DD, Cacciottola L, Pommé S, et al. Two-step transplantation with adipose tissue-derived stem cells increases follicle survival by enhancing vascularization in xenografted frozen-thawed human ovarian tissue[J]. Hum Reprod, 2018, 33(6): 1107-1116. [33] Parrott DMV. The fertility of mice with orthotopic ovarian graftes derived from frozen tissue[J]. Reprod Fertil, 1960, 1: 230-241. [34] Hovatta O, Silye R, Krausz T, et al. Cryopreservation of human ovarian tissue using dimethylsulphoxide and propanediol-sucrose as cryoprotectants[J]. Hum Reprod, 1996, 11(6): 1268-1272. [35] Oktay K, Newton H, Mullan J, et al. Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone[J]. Hum Reprod, 1998, 13(5): 1133-1138. [36] Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue[J]. N Engl J Med, 2000, 342(25): 1919. [37] Oktay K, Economos K, Kan M, et al. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm[J]. JAMA, 2001, 286(12): 1490-1493. [38] Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy[J]. N Engl J Med, 2005, 353(3): 318-321. [39] 阮祥燕, 杜娟, 卢丹, 等. 中国首例冻存卵巢组织移植报告[J]. 首都医科大学学报, 2016, 37(6): 840-842. [40] Ruan X, Du J, Lu D, et al. First pregnancy in China after ovarian tissue transplantation to prevent premature ovarian insufficiency[J]. Climacteric, 2021, 24(6): 624-628. [41] Ruan X, Du J, Lu D, et al. First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency[J]. Climacteric, 2022, 25(4): 421-424. [42] Yding Andersen C, Mamsen LS, Kristensen SG. FERTILITY PRESERVATION: freezing of ovarian tissue and clinical opportunities[J]. Reproduction, 2019, 158(5): F27-F34. [43] Dolmans MM, Amorim CA. FERTILITY PRESERVATION: construction and use of artificial ovaries[J]. Reproduction, 2019, 158(5): F15-F25. [44] Dolmans MM, Iwahara Y, Donnez J, et al. Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients[J]. Hum Reprod, 2016, 31(10): 2292-2302. [45] Jensen AK, Rechnitzer C, Macklon KT, et al. Cryopreservation of ovarian tissue for fertility preservation in a large cohort of young girls: focus on pubertal development[J]. Hum Reprod, 2016, 32(1): 154-164. [46] Donnez J, Dolmans MM. Fertility preservation in women[J]. N Engl J Med, 2017, 377(17): 1657-1665. [47] Telfer EE. FERTILITY PRESERVATION: progress and prospects for developing human immature oocytes in vitro[J]. Reproduction, 2019, 158(5): F45-F54. [48] Dadashzadeh A, Moghassemi S, Shavandi A, et al. A review on biomaterials for ovarian tissue engineering[J]. Acta Biomater, 2021, 135: 48-63. [49] Lee SH, Sung JH. Organ-on-a-chip technology for reproducing multiorgan physiology[J]. Adv Healthc Mater, 2018,7(2). doi: 10.1002/adhm.201700419. [50] Kristensen SG, Andersen CY. Cryopreservation of ovarian tissue: opportunities beyond fertility preservation and a positive view into the future[J]. Front Endocrinol(Lausanne), 2018, 9: 347. doi: 10.3389/fendo.2018.00347. [51] Oktay KH, Marin L, Petrikovsky B, et al. Delaying reproductive aging by ovarian tissue cryopreservation and transplantation: is it prime time?[J]. Trends Mol Med, 2021, 27(8): 753-761. [52] Kasaven LS, Saso S, Getreu N, et al. Age-related fertility decline: is there a role for elective ovarian tissue cryopreservation?[J]. Hum Reprod, 2022. doi: 10.1093/humrep/deac144. |
| [1] | 林芸,谢燕秋. 乳腺癌患者生育力保护及保存[J]. 山东大学学报 (医学版), 2022, 60(9): 42-46. |
| [2] | 吴瑞芳,李长忠. 女性生育力保护的现状与进展[J]. 山东大学学报 (医学版), 2022, 60(9): 1-7. |
| [3] | 颜磊,岳彩欣,刘懿淳. 子宫内膜异位症的生育力保护[J]. 山东大学学报 (医学版), 2022, 60(9): 31-34. |
| [4] | 秦静,杨飞,陈谦,夏涵岱,刘延国,王秀问. 晚期驱动基因阴性、PD-L1表达阴性非鳞非小细胞肺癌一线治疗方案的网状Meta分析[J]. 山东大学学报 (医学版), 2022, 60(7): 74-82. |
| [5] | 丁子琛,王浩桦,周立雯,丛慧文,李承圣,包绮晗,杨毅,王廉源,王素珍,石福艳. 基于贝叶斯累加回归树模型的非小细胞肺癌患者个性化疗效研究[J]. 山东大学学报 (医学版), 2022, 60(10): 92-98. |
| [6] | 初竹秀,赵文静,李小燕,孔晓丽,马婷婷,江立玉,杨其峰. 218例女性乳腺癌患者行新辅助化疗及伴随分子标志物改变的临床价值[J]. 山东大学学报 (医学版), 2021, 59(9): 130-139. |
| [7] | 王喆,刘玉洁,毛倩,管佩霞,包绮晗,李承圣,乔晓伟,潘庆忠,王素珍. 基于逆概率加权法的早期三阴性乳腺癌不同治疗方案的疗效评价[J]. 山东大学学报 (医学版), 2021, 59(8): 113-118. |
| [8] | 张小红,周云,杜秋莹,任慧欣,王超群. Atg7-siRNA通过调节精氨酸循环干扰食管癌ECA109细胞放疗敏感性[J]. 山东大学学报 (医学版), 2021, 59(4): 28-34. |
| [9] | 王浩,陆建,陈荔,查俊豪,郭金和. CT引导下碘125粒子植入治疗55例腹膜后恶性肿瘤的临床观察[J]. 山东大学学报 (医学版), 2020, 58(6): 65-70. |
| [10] | 郭田,付依林,高聆,宋勇峰,付国斌,耿冲,王潍博. 142例女性乳腺癌患者临床特征与甲状腺激素水平的关联分析[J]. 山东大学学报 (医学版), 2020, 58(6): 53-59. |
| [11] | 陈荣,李海超,赵健. 原发性纵隔精原细胞瘤1例报告及文献复习[J]. 山东大学学报 (医学版), 2020, 58(2): 79-84. |
| [12] | 张喜琴,祝守慧,刘宁,王玉,陈家帧,胡旭东. PEG-rhG-CSF对80例小细胞肺癌同步放化疗预防中性粒细胞减少的临床观察[J]. 山东大学学报 (医学版), 2020, 58(12): 43-46. |
| [13] | 王丹鹤,方文岩,张艳萍. 放射性125I粒子治疗肺腺癌伴沉默性骨骼肌转移瘤1例[J]. 山东大学学报 (医学版), 2020, 58(11): 118-120. |
| [14] | 阮祥燕,程姣姣,杜娟,李扬璐,金凤羽,Alfred O. Mueck. 生育力保护方法研究进展[J]. 山东大学学报 (医学版), 2019, 57(2): 29-34. |
| [15] | 侯巧妮,马会明,相丽,何艳桃,徐仙,陈冬梅,张雪玉. 人胎盘间充质干细胞移植对化疗所致卵巢早衰大鼠卵巢功能的影响[J]. 山东大学学报 (医学版), 2019, 57(2): 52-60. |
|
